Annual CAPEX
$4.85 M
-$4.94 M-50.47%
31 December 2022
Summary:
Mirati Therapeutics annual capital expenditures is currently $4.85 million, with the most recent change of -$4.94 million (-50.47%) on 31 December 2022. During the last 3 years, it has fallen by -$4.94 million (-50.47%).MRTX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$36.00 K
-$686.00 K-95.01%
30 September 2023
Summary:
Mirati Therapeutics quarterly capital expenditures is currently $36.00 thousand, with the most recent change of -$686.00 thousand (-95.01%) on 30 September 2023.MRTX Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$1.84 M
-$1.20 M-39.59%
30 September 2023
Summary:
Mirati Therapeutics TTM capital expenditures is currently $1.84 million, with the most recent change of -$1.20 million (-39.59%) on 30 September 2023.MRTX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRTX CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -50.5% | -98.6% | -81.3% |
| 5 y5 years | +212.6% | -97.3% | +18.4% |
MRTX CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -50.5% | -99.1% | -81.3% |
Mirati Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | $36.00 K(-95.0%) | $1.84 M(-39.6%) |
| June 2023 | - | $722.00 K(+168.4%) | $3.04 M(-23.6%) |
| Mar 2023 | - | $269.00 K(-66.8%) | $3.98 M(-18.0%) |
| Dec 2022 | $4.85 M(-50.5%) | $810.00 K(-34.7%) | $4.85 M(-27.5%) |
| Sept 2022 | - | $1.24 M(-25.3%) | $6.69 M(-10.3%) |
| June 2022 | - | $1.66 M(+45.7%) | $7.46 M(-24.1%) |
| Mar 2022 | - | $1.14 M(-57.0%) | $9.83 M(+0.3%) |
| Dec 2021 | $9.79 M(+124.3%) | $2.65 M(+31.9%) | $9.79 M(+13.2%) |
| Sept 2021 | - | $2.01 M(-50.1%) | $8.65 M(+7.1%) |
| June 2021 | - | $4.03 M(+264.0%) | $8.08 M(+53.9%) |
| Mar 2021 | - | $1.11 M(-26.5%) | $5.25 M(+20.2%) |
| Dec 2020 | $4.37 M(+181.4%) | $1.51 M(+4.9%) | $4.37 M(+4.1%) |
| Sept 2020 | - | $1.44 M(+19.6%) | $4.19 M(+44.2%) |
| June 2020 | - | $1.20 M(+436.2%) | $2.91 M(+63.7%) |
| Mar 2020 | - | $224.00 K(-83.2%) | $1.78 M(+14.4%) |
| Dec 2019 | $1.55 M(+1172.1%) | $1.33 M(+782.1%) | $1.55 M(+407.2%) |
| Sept 2019 | - | $151.00 K(+118.8%) | $306.00 K(+60.2%) |
| June 2019 | - | $69.00 K(-19.8%) | $191.00 K(+56.6%) |
| Dec 2018 | $122.00 K(+50.6%) | $86.00 K(+138.9%) | $122.00 K(+229.7%) |
| Sept 2018 | - | $36.00 K(+3500.0%) | $37.00 K(-54.3%) |
| Dec 2017 | $81.00 K(-58.7%) | $1000.00(>+9900.0%) | $81.00 K(-62.0%) |
| Sept 2017 | - | $0.00(-100.0%) | $213.00 K(-7.8%) |
| June 2017 | - | $80.00 K(-39.8%) | $231.00 K(+17.9%) |
| Dec 2016 | $196.00 K(-40.4%) | $133.00 K(+638.9%) | $196.00 K(+104.2%) |
| Sept 2016 | - | $18.00 K(>+9900.0%) | $96.00 K(+24.7%) |
| June 2016 | - | $0.00(-100.0%) | $77.00 K(-78.4%) |
| Mar 2016 | - | $45.00 K(+36.4%) | $356.00 K(+8.2%) |
| Dec 2015 | $329.00 K(-14.8%) | $33.00 K(-3400.0%) | $329.00 K(-9.1%) |
| Sept 2015 | - | -$1000.00(-100.4%) | $362.00 K(-13.6%) |
| June 2015 | - | $279.00 K(+1450.0%) | $419.00 K(+4.2%) |
| Mar 2015 | - | $18.00 K(-72.7%) | $402.00 K(+4.1%) |
| Dec 2014 | $386.00 K(+89.2%) | $66.00 K(+17.9%) | $386.00 K(+17.7%) |
| Sept 2014 | - | $56.00 K(-78.6%) | $328.00 K(+5.1%) |
| June 2014 | - | $262.00 K(>+9900.0%) | $312.00 K(+169.0%) |
| Mar 2014 | - | $2000.00(-75.0%) | $116.00 K(-43.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | $204.00 K(-11.3%) | $8000.00(-80.0%) | $204.00 K(-42.9%) |
| Sept 2013 | - | $40.00 K(-39.4%) | $357.00 K(+6.6%) |
| June 2013 | - | $66.00 K(-26.7%) | $335.00 K(+5.3%) |
| Mar 2013 | - | $90.00 K(-44.1%) | $318.00 K(+38.3%) |
| Dec 2012 | $230.00 K(+115.4%) | $161.00 K(+794.4%) | $230.00 K(+133.0%) |
| Sept 2012 | - | $18.00 K(-63.3%) | $98.70 K(-36.2%) |
| June 2012 | - | $49.00 K(+2350.0%) | $154.70 K(+42.2%) |
| Mar 2012 | - | $2000.00(-93.3%) | $108.80 K(+1.9%) |
| Dec 2011 | $106.80 K(+1425.7%) | $29.70 K(-59.9%) | $106.80 K(+40.0%) |
| Sept 2011 | - | $74.00 K(+2287.1%) | $76.30 K(+1339.6%) |
| June 2011 | - | $3100.00(-487.5%) | $5300.00(-23.2%) |
| Dec 2010 | $7000.00(-85.0%) | -$800.00(-126.7%) | $6900.00(-82.5%) |
| Sept 2010 | - | $3000.00(-1600.0%) | $39.50 K(-9.6%) |
| June 2010 | - | -$200.00(-104.1%) | $43.70 K(-15.5%) |
| Mar 2010 | - | $4900.00(-84.6%) | $51.70 K(+10.5%) |
| Dec 2009 | $46.80 K(-78.3%) | $31.80 K(+341.7%) | $46.80 K(-164.9%) |
| Sept 2009 | - | $7200.00(-7.7%) | -$72.10 K(-214.8%) |
| June 2009 | - | $7800.00(-109.0%) | $62.80 K(-70.9%) |
| Dec 2008 | $216.10 K(-85.4%) | -$87.10 K(-161.3%) | $216.10 K(-78.9%) |
| Sept 2008 | - | $142.10 K(+166.6%) | $1.03 M(-6.9%) |
| June 2008 | - | $53.30 K(-50.6%) | $1.10 M(-17.3%) |
| Mar 2008 | - | $107.80 K(-85.1%) | $1.33 M(-10.2%) |
| Dec 2007 | $1.48 M(+55.0%) | $722.90 K(+232.1%) | $1.48 M(+40.6%) |
| Sept 2007 | - | $217.70 K(-23.5%) | $1.06 M(-2.9%) |
| June 2007 | - | $284.50 K(+9.7%) | $1.09 M(+3.0%) |
| Mar 2007 | - | $259.30 K(-11.8%) | $1.05 M(+10.1%) |
| Dec 2006 | $957.40 K(-32.2%) | $293.90 K(+18.2%) | $957.50 K(+42.1%) |
| Sept 2006 | - | $248.70 K(-1.5%) | $673.60 K(+17.9%) |
| June 2006 | - | $252.40 K(+55.3%) | $571.10 K(-54.5%) |
| Mar 2006 | - | $162.50 K(+1525.0%) | $1.26 M(-10.9%) |
| Dec 2005 | $1.41 M(+84.3%) | $10.00 K(-93.2%) | $1.41 M(+0.7%) |
| Sept 2005 | - | $146.20 K(-84.4%) | $1.40 M(+11.7%) |
| June 2005 | - | $937.80 K(+195.8%) | $1.25 M(+295.8%) |
| Mar 2005 | - | $317.00 K | $317.00 K |
| Dec 2004 | $765.80 K(-18.0%) | - | - |
| Dec 2003 | $934.10 K | - | - |
FAQ
- What is Mirati Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Mirati Therapeutics?
- What is Mirati Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Mirati Therapeutics?
- What is Mirati Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for Mirati Therapeutics?
What is Mirati Therapeutics annual capital expenditures?
The current annual CAPEX of MRTX is $4.85 M
What is the all time high annual CAPEX for Mirati Therapeutics?
Mirati Therapeutics all-time high annual capital expenditures is $9.79 M
What is Mirati Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of MRTX is $36.00 K
What is the all time high quarterly CAPEX for Mirati Therapeutics?
Mirati Therapeutics all-time high quarterly capital expenditures is $4.03 M
What is Mirati Therapeutics TTM capital expenditures?
The current TTM CAPEX of MRTX is $1.84 M
What is the all time high TTM CAPEX for Mirati Therapeutics?
Mirati Therapeutics all-time high TTM capital expenditures is $9.83 M